METTL3-Mediated m6A Modification of lncRNA-0949 Drives Microglial Inflammation in an vitro Model of Sepsis-Associated Encephalopathy
Year: 2026
Type: article
Abstract: Introduction: Sepsis-associated encephalopathy (SAE) is a severe complication of sepsis with limited therapeutic options. Although neuroinflammation driven by microglial activation is central to SAE pathogenesis, the underlying epitranscriptional regulatory mechanisms remain poorly defined. Here, we investigated the role of the m 6 A methyltransferase METTL3 in regulating microglial inflammation using lipopolysaccharide (LPS)-stimulated HMO6 microglial cells as an in vitro SAE model. Methods: HMO6 cells were stimulated with LPS (1 μg/mL) for 0– 24 h to establish an SAE model. METTL3 expression was assessed by Western blotting and immunofluorescence. MeRIP-qPCR was used to detect m 6 A deposition on lncRNA-0949. METTL3 was inhibited pharmacologically (3-DAA) or by siRNA knockdown. lncRNA-0949 stability was evaluated by actinomycin D chase assay. Luciferase reporters containing wild-type or m 6 A site-mutated lncRNA-0949 3′UTR were constructed to identify functional m 6 A sites. Wild-type and m 6 A site-mutated lncRNA-0949 overexpression vectors were employed to assess modification-dependent pro-inflammatory function. Cytokine mRNA (qRT-PCR) and protein (ELISA) levels were measured. Results: LPS stimulation time-dependently increased oxidative stress (MDA), pro-inflammatory cytokines (MIP-2, IL-1β, TNF-α, IL-6), and METTL3 protein expression (2.99-fold at 24 h, P < 0.001). METTL3 catalyzed m 6 A deposition on lncRNA-0949, with enrichment reaching 21.3-fold at 24 h post-LPS (P < 0.001). METTL3 knockdown abolished this modification and reduced lncRNA-0949 stability, decreasing its half-life from ~30 h to 11 h (P < 0.001). The m 6 A site within the 3′UTR (RRACH motif) was essential for LPS-induced reporter activity (7.7-fold increase for WT vs. no response for Mut, P < 0.001). Overexpression of wild-type lncRNA-0949 amplified LPS-triggered cytokine release (eg, TNF-α increased by additional 33%, P < 0.001), whereas the m 6 A site mutant had no effect. Conversely, METTL3 knockdown attenuated LPS-induced inflammatory responses, with mRNA levels reduced by 35– 58% and protein levels by 30– 63% (all P < 0.001). Conclusion: Together, these findings define a METTL3–m6A–lncRNA-0949 regulatory axis that amplifies microglial inflammation in an in vitro SAE model. This study provides the first evidence that METTL3-driven m6A modification of lncRNA-0949 contributes to neuroinflammation, offering a new mechanistic perspective and highlighting the need for in vivo validation to assess therapeutic potential. Keywords: LncRNA-0949, septic encephalopathy, METTL3, inflammation
Source: Journal of Inflammation Research
DOI: 10.2147/jir.s590579
Institution: First Affiliated Hospital of Nanchang University
Language: English
Topic: RNA modifications and cancer
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W7164209927
